Karl Trambauer

Title: The Innovative Mind of Karl Trambauer

Introduction

Karl Trambauer, an ingenious inventor based in Vienna, Austria, holds a notable portfolio of two patents. His groundbreaking work primarily concentrates on methods to inactivate pathogens in blood plasma and blood products, showcasing an essential contribution to medical safety and innovation.

Latest Patents

Trambauer's latest patents reflect his dedication to improving health technologies. The first patent describes a "Method of Inactivating Reproducible Filterable Pathogens in Blood Plasma." This innovative approach involves heat treating blood plasma products in a solid state within a closed inactivation container, utilizing elevated temperatures along with specific amounts of water and organic compounds. The process is designed to ensure that water remains physically bound to the plasma, while organic compounds are present as gases in the atmosphere. The precise water content for optimal efficacy ranges from 0.08 to 0.40, and the concentration of organic compounds in the gaseous phase is maintained between 0.01 and 10 grams per liter of container volume.

The second patent emphasizes a similar theme, focusing on a "Method of Inactivating Viruses in Blood Products." This method incorporates heat treatment under either humid or solid-state conditions, utilizing inorganic or organic hydroxyl group-containing compounds. These compounds, which may include water, methanol, ethanol, or mannitol, significantly enhance the inactivation process at temperatures that can reach up to 121 degrees Celsius, and treatment periods lasting from 1 second to 100 hours. This method is advantageous for producing critical blood products, including enzymes, coagulation factors, immunoglobulins, and more, ensuring any pathogens present are effectively destroyed.

Career Highlights

Trambauer's professional journey includes his position at Immuno Aktiengesellschaft für Chemisch-Medizinische Produkte, a company acknowledged for its commitment to developing medical solutions. His inventions are crucial in advancing the field of transfusion medicine and blood safety.

Collaborations

Throughout his career, Trambauer has collaborated with esteemed colleagues, including Johann J. Eibl and Otto Schwarz. Their collective efforts have significantly enhanced research and development within the biopharmaceutical sector, further emphasizing the importance of collaboration in driving innovation.

Conclusion

Karl Trambauer’s contributions through his patents highlight the impact of innovative thinking in the medical field. His dedication to enhancing the safety of blood products demonstrates how targeted inventions can revolutionize health practices, establishing a lasting legacy in the world of biotechnology and medical safety.